首页> 外文期刊>Annals of allergy, asthma, and immunology >Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis
【24h】

Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis

机译:家庭皮下免疫球蛋白疗法与医院静脉内免疫球蛋白治疗:预期经济分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Home-based subcutaneous immunoglobulin (SCIg) administration used for immunoglobulin replacement therapy for patients with primary immunodeficiency has been demonstrated to have benefits compared with hospital-based intravenous immunoglobulin (IVIg) therapy.
机译:背景技术与初级免疫缺陷患者的免疫球蛋白替代疗法用于免疫球蛋白替代治疗的家庭皮下免疫球蛋白(SCIG)给药,与基于医院的静脉内免疫球蛋白(IVIG)治疗相比具有益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号